MedPath

Investigation the Effect of vaginal Evening Primrose capsule on cervical preparation for childbirth

Phase 3
Conditions
Bishop Score.
Registration Number
IRCT20160308026971N4
Lead Sponsor
Rafsanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
86
Inclusion Criteria

Inclination to participate in the study
Tendency to normal delivery
Selection of Niknafs hospital for delivery
Mother’s age is 18-35 years
Gestational age 38 weeks based on first trimester Ultrasonography or reliable IMP
Single fetus with cephalic presentation The basis of the results of the last ultrasound
Nulliparality
the integrity of the embryonic membranes

Exclusion Criteria

Non-use of two successive capsules of Primrose
Primrose capsule susceptibility
Emergency intervention for maternal or embryonic reasons
Unwillingness of the research unit to continue cooperation
Vaginal bleeding
Presence of contraindications for use of Evening Primrose capsule (diseases associated with disorders Hemorrhagic agents, anticoagulant drugs, Patients with history of psychiatric disorders in the phenothiazine category, and epilepsy patients)
History of known chronic disease
Pregnancy complications such as Hydromenosis, Oligohydroamenia, Pre-eclampsia, Eclampsia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bishop score. Timepoint: After intervention. Method of measurement: Physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath